FRIDAY, Dec. 8, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved two milestone gene therapies for sickle cell disease, including the first treatment ever approved that uses gene-editing technology. Casgevy, developed by Vertex Pharmaceuticals of Boston and CRISPR Therapeutics of Switzerland, is the first medicineContinue Reading

MONDAY, Nov. 20, 2023 (HealthDay News) — Lab-grown blood vessels are providing new insight into how damage to the tiny vessels in the brain can cause them to leak, contributing to dementia and stroke. Even better, this research has identified a drug target that could plug these leaks and potentiallyContinue Reading

MONDAY, Oct. 30, 2023 (HealthDay News) — Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition, which typically strikes Black people. The agencyContinue Reading

TUESDAY, Sept. 12, 2023 (HealthDay News) — It’s possible that the cause of spontaneous, recurring brain hemorrhages can be passed through blood transfusion, researchers say. The likelihood of this happening is very slim, however. Still, “blood transfusions are relatively common, which makes possible negative effects an important public health issue,”Continue Reading

FRIDAY, Sept. 8, 2023 (HealthDay News) — It’s well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk. The study, of 2 million Danish women, found what numerous others have before:Continue Reading

THURSDAY, June 15, 2023 (HealthDay News) — Intermittent fasting is all the rage due to the lengthy list of health benefits associated with this style of eating. Now, a new, small study suggests that one type of intermittent fasting — early time-restricted eating — may be key for preventing typeContinue Reading